Tumor stage (Figure 6C) and tumor grade (Figure 6D) were found to be highly correlated with the mRNA expression level of DTYMK in HCC patients, indicating high DTYMK expression probably associated with poor clinical characteristics. This evidence concerns the gene DTYMK and hepatocellular carcinoma.